Press Releases

SynCardia Systems Announces First-Ever FDA Approval
of Total Artificial Heart

Oct. 18, 2004

SynCardia Systems, a privately held developer of biomechanical cardiac replacement and assist devices, announced today that the U.S. Food and Drug Administration (FDA) approved its CardioWest™ temporary Total Artificial Heart... read more

SynCardia Systems Appoints Carole E. Marcot to Vice President of Quality and Regulatory Affairs

Sept. 1, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, today announced the appointment of Carole E. Marcot... read more

New England Journal of Medicine Publishes Results of Five Center Study
on SynCardia’s CardioWest™ temporary Total Artificial Heart

Aug. 25, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, today announced that the August 26 issue of the New England Journal of Medicine features the results of the multi-center study... read more

Journal of Heart and Lung Transplantation Publishes Study
on SynCardia’s CardioWest™ temporary Total Artificial Heart

Aug. 17, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, today announced that a single center nine year heart study has been published... read more

SynCardia Systems Appoints Michael J. Quinn to Board of Directors

June 16, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, today announced the appointment of Michael J. Quinn to its Board of Directors... read more

SynCardia Systems Closes $3.7 Million Series B Financing

May 24, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, announced today the completion of a Series B financing of $3.7 million... read more

SynCardia Systems Appoints Rodger G. Ford to Board of Directors

May 11, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, announced today the appointment of Rodger G. Ford to its Board of Directors... read more

Panel Recommends FDA Approval, with Conditions,
of SynCardia Systems CardioWest™ temporary Total Artificial Heart

March 18, 2004

SynCardia Systems, a privately held developer of biomechanical cardiac replacement and assist devices, announced today that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Panel met yesterday and recommended that the CardioWest™ temporary Total Artificial Heart (TAH-t) be approved, with conditions, by the FDA... read more

SynCardia Systems Announces FDA Panel Review Date
for its CardioWest™ temporary Total Artificial Heart

March 12, 2004

SynCardia Systems, Inc., a privately held developer of biomechanical cardiac replacement and assist devices, announced today that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Panel will discuss... read more